Supernus Pharmaceuticals Inc (SUPN) earnings · rev $719.0M
These earnings events as JSON? API free 100/daySupernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This SUPN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SUPN revenue for 2025-12-31 was $719.0M. Net income was -$38.5M. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. SUPN currently screens at market cap $2.53B.
When the next SUPN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 8.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SUPN research stays on the stock page; the tape stays on the quote page.
SUPN earnings FAQ
What are SUPN's latest revenue and net income?
Latest cached Supernus Pharmaceuticals Inc (SUPN) revenue for Dec 31, 2025 was $719.0M. Net income was -$38.5M. Statements: https://lician.com/financials/supn
What is SUPN's latest diluted EPS?
Latest cached Supernus Pharmaceuticals Inc (SUPN) diluted EPS for Dec 31, 2025 was -$0.68.
What period does the latest SUPN earnings print cover?
The latest cached Supernus Pharmaceuticals Inc (SUPN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did SUPN revenue change from the prior cached period?
Cached Supernus Pharmaceuticals Inc (SUPN) revenue was up 8.6% from $661.8M (Dec 31, 2024) to $719.0M (Dec 31, 2025). Statements: https://lician.com/financials/supn
Where are SUPN earnings listed?
Cached earnings facts for Supernus Pharmaceuticals Inc (SUPN) are listed at https://lician.com/earnings/supn. Statements: https://lician.com/financials/supn
Not investment advice.